JNJ

#17
Johnson & Johnson
237.82 USD
-0.04%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
237.22
240.69
Годовой диапазон
146.12
251.71
Дневное изменение
-0.04%
Месячное изменение
-2.53%
6-месячное изменение
+24.74%
Годовое изменение
+52.74%
Предыдущее закрытие
237.91
Открыть
239.30
Bid
Ask
Минимум
237.22
High
240.69
Объем
2 256
Открыть полный график

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
  • Market Capitalization 573.12 B
  • Employee 141 K
  • Founded N/A
  • CEO Joaquin Duato
  • Website www.jnj.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BMHYD1
  • Industry Technology
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
18.82
Коэффициент цена/денежный поток
5.35
Дивиденды на акцию
5.14
Дивидендная доходность, %
2.48

Johnson & Johnson

Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA. Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings.

Новости